文献速递神经头颈儿科影像MR

高分辨率MRI整合定性影像特征、视神经测量与肿瘤影像组学增强视网膜母细胞瘤筛板后视神经侵犯预测

Enhanced prediction of postlaminar optic nerve invasion in retinoblastoma using high-resolution MRI: integrating qualitative imaging features, optic nerve measurements and tumor radiomics.
PubMed 文献 · Eur Radiol · 2025-11-14

这项回顾性多中心病例对照研究纳入128例视网膜母细胞瘤患者(30眼病理证实筛板后视神经侵犯,146眼对照),比较手动与自动视神经直径测量,并构建整合影像组学与临床特征的逻辑回归模型。手动远端视神经直径测量AUC为0.85,显著优于自动法的0.68(p < 0.001);最终模型AUC达0.90(95% CI: 0.86, 0.95)。

要点

  • 手动远端视神经直径测量预测筛板后视神经侵犯的AUC为0.85,显著优于自动分割模型的0.68(p < 0.001)。
  • 整合影像组学、视神经宽度与定性PLONI表现的逻辑回归模型AUC为0.90(95% CI: 0.86, 0.95),优于其他模型。
  • 定性PLONI评估由两名专家放射科医生完成,并作为特征纳入最终预测模型。

核心结论

  • 研究开发了预测视网膜母细胞瘤筛板后视神经侵犯的高性能模型,凸显先进MR成像及定性与定量特征整合的价值,可能为临床医生提供额外工具以指导治疗决策。

研究设计与样本

  • 回顾性、多中心病例对照研究,纳入128例经组织病理学确诊的视网膜母细胞瘤患者,共30眼病理证实PLONI、146眼无PLONI对照,使用治疗前高空间分辨率MR图像。

诊断标准与关键数值

  • 手动远端视神经直径测量检测PLONI的AUC为0.85,自动分割模型为0.68(p < 0.001);最终逻辑回归模型AUC为0.90(95% CI: 0.86, 0.95,SD 0.07)。

临床应用与阅片要点

  • 作者认为该模型通过增强风险评估,可能为临床医生提供指导治疗决策、优化早期干预策略的额外工具,最终改善视网膜母细胞瘤管理的患者照护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to develop a model for predicting postlaminar optic nerve invasion (PLONI) in retinoblastoma patients using MR imaging. The model was designed to incorporate recent advanced diagnostic techniques, including tumor radiomics, manual and automatic distal optic nerve width measurements, and qualitative PLONI assessments.

MATERIALS AND METHODS: This retrospective, multicenter case-control study included patients with histopathologically confirmed PLONI and high-spatial-resolution pretreatment MR images. PLONI appearance was qualitatively assessed by two expert radiologists. Quantitative measurements of optic nerve diameter were automatically obtained using a segmentation model and compared to manual measurements by the radiologist using the area under the curve (AUC). The best-performing optic nerve measurements, along with clinical features and radiomic features derived from tumor delineations, were used for prediction modeling.

RESULTS: One hundred twenty-eight retinoblastoma patients (median age, 22 months [range, 0-113], 58 female) were included in this study. This resulted in 30 eyes with histopathologically proven PLONI and 146 control eyes without PLONI. Manual distal optic nerve diameter measurements were chosen for prediction modeling, as this significantly outperformed the automatic approach for detecting PLONI, achieving an AUC of 0.85 compared to 0.68 (p < 0.001) for the automatic method. The final logistic regression model, which integrated radiomic features and clinical features including optic nerve width and PLONI appearance MR imaging, achieved an AUC of 0.90 (95% CI: 0.86, 0.95, SD 0.07), outperforming the other models.

CONCLUSION: This study developed a high-performing model for predicting PLONI, highlighting the value of advanced MR imaging and the integration of both qualitative and quantitative features. By enhancing risk assessment, this model could provide clinicians with an additional tool for guiding treatment decisions, optimizing early intervention strategies, and ultimately improving patient care in retinoblastoma management.

KEY POINTS: Question Accurately detecting postlaminar optic nerve invasion in retinoblastoma remains challenging. Improved imaging-based prediction methods are needed to optimize risk assessment and potentially treatment decisions. Findings Manual distal optic nerve width measurements combined with qualitative imaging features and radiomics achieved high diagnostic performance for predicting postlaminar optic nerve invasion in retinoblastoma. Clinical relevance This study improves the prediction of postlaminar optic nerve invasion in retinoblastoma by integrating qualitative imaging assessments, optic nerve measurements, and radiomics, enhancing early detection and thus potentially reducing unnecessary aggressive treatments.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. de Bloeme CM, van Elst S, Göricke S, et al. Enhanced prediction of postlaminar optic nerve invasion in retinoblastoma using high-resolution MRI: integrating qualitative imaging features, optic nerve measurements and tumor radiomics. Eur Radiol. 2025. PMID: 41238767. doi:10.1007/s00330-025-12123-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。